- Home
- TRNS vs PRAX Comparison
TRNS vs PRAX Comparison
Compare TRNS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNS
- PRAX
- Stock Information
- Founded
- TRNS 1964
- PRAX 2015
- Country
- TRNS United States
- PRAX United States
- Employees
- TRNS N/A
- PRAX N/A
- Industry
- TRNS Electrical Products
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- TRNS Industrials
- PRAX Health Care
- Exchange
- TRNS Nasdaq
- PRAX Nasdaq
- Market Cap
- TRNS 842.7M
- PRAX 950.8M
- IPO Year
- TRNS N/A
- PRAX 2020
- Fundamental
- Price
- TRNS $72.61
- PRAX $44.03
- Analyst Decision
- TRNS Buy
- PRAX Strong Buy
- Analyst Count
- TRNS 4
- PRAX 9
- Target Price
- TRNS $108.67
- PRAX $94.44
- AVG Volume (30 Days)
- TRNS 115.1K
- PRAX 383.5K
- Earning Date
- TRNS 10-27-2025
- PRAX 11-05-2025
- Dividend Yield
- TRNS N/A
- PRAX N/A
- EPS Growth
- TRNS N/A
- PRAX N/A
- EPS
- TRNS 1.44
- PRAX N/A
- Revenue
- TRNS $288,138,000.00
- PRAX $7,765,000.00
- Revenue This Year
- TRNS $16.67
- PRAX N/A
- Revenue Next Year
- TRNS $9.14
- PRAX $22.22
- P/E Ratio
- TRNS $50.20
- PRAX N/A
- Revenue Growth
- TRNS 8.49
- PRAX 338.45
- 52 Week Low
- TRNS $67.56
- PRAX $26.70
- 52 Week High
- TRNS $133.72
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- TRNS 35.50
- PRAX 48.77
- Support Level
- TRNS $75.30
- PRAX $37.25
- Resistance Level
- TRNS $79.89
- PRAX $40.69
- Average True Range (ATR)
- TRNS 3.12
- PRAX 2.54
- MACD
- TRNS -1.05
- PRAX -0.03
- Stochastic Oscillator
- TRNS 10.05
- PRAX 61.04
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.